Orbactiv sales history revenue
WebORBACTIV infusion in patients with a history of glycopeptide allergy. In the Phase 3 ABSSSI clinical trials, the median onset of hypersensitivity reactions in ORBACTIV-treated patients was 1.2 days and the median duration of these reactions was 2.4 days. [see Adverse Reactions (6.1)] 5.4 . Infusion Related Reactions Web2.2 Preparation of ORBACTIV for Intravenous Infusion . ORBACTIV is intended for intravenous infusion, only after reconstitution and dilution. Three ORBACTIV 400 mg vials need to be reconstituted and diluted to prepare a single 1200 mg intravenous dose. Reconstitution: Aseptic technique should be used to reconstitute three ORBACTIV 400 mg …
Orbactiv sales history revenue
Did you know?
Oritavancin, sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin. The U.S. Food and Drug Administration (FDA) and … See more Oritavancin shares certain properties with other members of the glycopeptide class of antibiotics, which includes vancomycin, the current standard of care for serious Gram-positive infections in the United States and Europe. It … See more Oritavancin is active against gram-positive aerobic bacteria such as enterococci, staphylococci, streptococci, and anaerobic bacteria such as See more Originally discovered and developed by Eli Lilly, oritavancin was acquired by InterMune in 2001 and then by Targanta Therapeutics in … See more In 2003, results were presented from two pivotal phase-III clinical trials testing the efficacy of daily intravenous oritavancin for the treatment of acute bacterial skin and skin-structure infections (ABSSSI) caused by Gram-positive bacteria. The primary endpoints of … See more • "Oritavancin". Drug Information Portal. U.S. National Library of Medicine. See more WebFeb 22, 2024 · Orbactiv IV is a prescription medicine used to treat the symptoms of Acute Bacterial Skin and Skin Structure Infections. Orbactiv IV may be used alone or with other medications. Orbactiv IV belongs to a class of drugs called Glycopeptides. It is not known if Orbactiv IV is safe and effective in children younger than 18 years of age.
WebHeadquarters United States Website www.orbactiv.com Revenue <$5M Is this data correct? Popular Searches Orbactiv SIC Code 28,283 NAICS Code 32,325 Show More Top … WebORBACTIV is contraindicated in patients with known hypersensitivity to ORBACTIV. 5 WARNINGS AND PRECAUTIONS 5.1 Coagulation Test Interference . ORBACTIV has been shown to artificially prolong aPTT for up to 120 hours, PT and INR for up to 12 hours, and activated clotting time (ACT) for up to 24 hours following administration of a
Weboritavancin (Rx) Brand and Other Names: Kimyrsa, Orbactiv Classes: Glycopeptides Dosing & Uses AdultPediatric Dosage Forms & Strengths injection, lyophilized powder for reconstitution... WebORBACTIV® is contraindicated in patients with known hypersensitivity to oritavancin products. Warnings and Precautions Coagulation test interference: Oritavancin has been …
WebFeb 25, 2024 · ORBACTIV is intended for intravenous infusion, only after reconstitution and dilution. Three ORBACTIV 400 mg vials need to be reconstituted and diluted to prepare a single 1,200 mg intravenous dose. Reconstitution: Aseptic technique should be used to reconstitute three ORBACTIV 400 mg vials.
WebTable 1: Orbactiv, Description Table 2: Product Details Table 3: Orbactiv, Historical Sales till 2024 (in million USD) Table 4: Orbactiv, Forecasted Sales from 2024-2024 (in million USD) … scr little foxesWebOrbactiv Revenue $3.1 M Employees 14 Primary Industries Manufacturing Pharmaceuticals Top Orbactiv Integrations and Technologies Here's a list of some of the top trending … pcb to wire headersWebFacilitating access to Orbactiv® (oritavancin) for your patients. 1-844-ORBACTIV (1-844-672-2284) Monday - Friday, 8:00 AM - 8:00 PM ET or email us. Medical Information. For medical inquiries or to report an adverse event, other safety related information, or product complaints for a company product, please contact Medical Information. ... pcb toxic effectsWebMar 13, 2024 · In the fourth quarter, sales of commercial products increased 32% compared to the third quarter of 2024, driven by strong Vabomere ® (meropenem and vaborbactam) … pcb tourist taxWebFeb 22, 2024 · Orbactiv (oritavancin) for injection is an antibiotic used to treat adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following Gram -positive microorganisms: Staphylococcus aureus (including methicillin -susceptible and methicillin-resistant isolates), Streptococcus pyogenes, … scr latch currentWebFeb 1, 2024 · Orbactiv is intended for intravenous infusion, only after reconstitution and dilution. Three Orbactiv 400 mg vials need to be reconstituted and diluted to prepare a … scrlicsWeb*INDICATION AND USAGE. Both KIMYRSA ® and ORBACTIV ® are oritavancin products that are indicated for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI) caused or suspected to be caused by susceptible isolates of the following gram-positive microorganisms: Staphylococcus aureus (including methicillin … pcb to schematic